Recent FDA approvals have expanded the indication for semaglutide to include the reduction of major adverse cardiovascular events (MACE), such as heart attack, stroke, and cardiovascular death, in adults with established cardiovascular disease and obesity
1 The side effects were consistent with what you'd expect from GLP-1-class drugs: nausea, diarrhea, constipation, and decreased appetite were the most common
No escaping the hype
Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, and Rosebraugh C
The Batsis review answers this directly
Three months earlier, in April 2023, two supplement companies, NOW Foods and Fungi Perfecti, separately reported counterfeit versions of their products sold on Amazon